Bumper Offer - Urjas oil Just @ Rs. 1
Laregab At is a prescription drug, available for use as Tablet. Secondary and off-label uses of Laregab At have also been mentioned below.
The optimal dosage of Laregab At is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
Some other side effects of Laregab At have been listed ahead. Usually, these side effects of Laregab At go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
In addition, Laregab At's effect is Moderate during pregnancy and Moderate for lactating mothers. Warnings related to Laregab At's effects on the liver, heart and kidney, if any, have been listed below.
Laregab At is not recommended if you suffer from certain medical conditions as it can have adverse effects. Heart Disease, Heart Failure, Arrhythmia are examples of such conditions. Other conditions have been mentioned below in the Laregab At contraindications section.
Drug interactions for Laregab At have been reported in the medical literature. See below for a complete list.
You should also be aware that Laregab At is not safe while driving, and is not addiction.
Laregab At is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Laregab At is used -
Moderate
Mild
Is the use of Laregab At safe for pregnant women?
Laregab At can have harmful effects in pregnant women. If you experience any discomfort after using Laregab At, then discontinue the use and take your doctor's advice.
Is the use of Laregab At safe during breastfeeding?
Laregab At may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Laregab At, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Laregab At.
What is the effect of Laregab At on the Kidneys?
Laregab At has very mild side effects on the kidneys.
What is the effect of Laregab At on the Liver?
There are no any side effects of Laregab At on the liver.
What is the effect of Laregab At on the Heart?
Using Laregab At does not have any harmful effects on the heart.
Laregab At should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Laregab At unless your doctor advises you to do so -
Is this Laregab At habit forming or addictive?
Yes, you can get addicted to Laregab At. It is essential that you take [medicine] only after doctor's recommendation.
Interaction between Food and Laregab At
Taking Laregab At with food does not cause any problems.
Interaction between Alcohol and Laregab At
Taking Laregab At with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amitriptyline Hydrochloride
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 454,458
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 145-147
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Neurontin® (gabapentin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 419-420
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 605-606
